SCHEMBL453462

SCHEMBL453462

CC(C)O[Ti]OC(C)C.CCOC(=O)CC(C)=O.CCOC(=O)CC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.50
MGAM O43451 2/20 0.50
SI P14410 2/20 0.50
MGAM2 Q2M2H8 2/20 0.50
ALDH1A1 P00352 5/20 0.38
TRPA1 O75762 1/20 0.38
LMNA P02545 2/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.34
CYP1A2 P05177 1/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
NLRP3 Q96P20 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28370473 1.00 GAA (0.50) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL430611 0.86 GAA (0.47) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL8699874 0.86 MGAM (0.38) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL1361825 0.86 GAA (0.47) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL8703581 0.83 ALDH1A1 (0.44) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL28374616 0.82 MGAM (0.62) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL1277958 0.82 MGAM (0.62) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL28111990 0.82 GAA (0.56) GAAMGAMSIMGAM2ALDH1A1
Isopropyl Alcohol SCHEMBL4612528 0.82 GAA (0.61) GAAMGAMSIMGAM2ALDH1A1
Isopropyl Alcohol SCHEMBL4264567 0.82 GAA (0.61) GAAMGAMSIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 472 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230050175-A1 CURABLE ORGANOPOLYSILOXANE COMPOSITION, CURED PRODUCT THEREOF, PROTECTIVE AGENT OR ADHESIVE, AND ELECTRIC/ELECTRONIC DEVICE DOW TORAY CO., LTD. (JP) 2023-02-16 US claimed
US-8754165-B2 Heat-conductive silicone grease composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-06-17 US claimed
US-7632909-B2 Self-adhesive organopolysiloxane composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-15 US claimed
US-5356954-A Blending polysiloxane with silane compound containing at least 3 hydrolyzable groups, blending with particulate light colored filler DOW CORNING TORAY SILICONE CO., LTD. (JP) 1994-10-18 US claimed
EP-4703406-A1 HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT Kaneka Corporation (JP) 2026-03-04 EP disclosed
EP-4703367-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT Kaneka Corporation (JP) 2026-03-04 EP disclosed
US-20260049176-A1 HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT KANEKA CORPORATION (JP) 2026-02-19 US disclosed
US-20260049182-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT KANEKA CORPORATION (JP) 2026-02-19 US disclosed
EP-4682204-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2026-01-21 EP disclosed
US-12516217-B2 Primer composition and curtain wall unit SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-01-06 US disclosed
EP-3929260-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2025-12-17 EP disclosed
EP-4656672-A1 METHOD FOR PRODUCING CURABLE COMPOSITION Kaneka Corporation (JP) 2025-12-03 EP disclosed
EP-0512562-A2 Method of forming coating films KANSAI PAINT CO., LTD. (JP) 1992-11-11 EP disclosed
EP-0483776-A2 Room temperature-curable organopolysiloxane composition Dow Corning Toray Silicone Company, Limited (JP) 1992-05-06 EP disclosed
US-4973644-A MERCAPTO CONTAINING ALKOXYSILANE, STORAGE STABILITY TORAY SILICONE COMPANY, LTD. (JP) 1990-11-27 US disclosed
EP-0345645-A2 Room temperature-curable organopolysiloxane composition TORAY SILICONE COMPANY, LIMITED (JP) 1989-12-13 EP disclosed
EP-0304958-A2 Room temperature-curable organopolysiloxane composition TORAY SILICONE COMPANY, LIMITED (JP) 1989-03-01 EP disclosed
EP-0028137-B1 DRY PLANOGRAPHIC PRINTING PLATE TORAY INDUSTRIES, INC. (JP) 1984-12-05 EP disclosed
US-4308799-A POLYSILOXANE, ALKOXYSILANE, AND ORGANOTITANIUM OR ZIRCONIUM COMPOUND TORAY INDUSTRIES, INC. (JP) 1982-01-05 US disclosed
EP-0028137-A1 Dry planographic printing plate TORAY INDUSTRIES, INC. (JP) 1981-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049176-A1 HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT PSMA1, LIPA, SGMS1 GAA 145/4885MGAM 291/4885SI 413/4885
US-20260049182-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT ILK, CROCC, SEM1 GAA 2153/4885MGAM 1685/4885SI 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.